OverviewChartNewsTraderScreen

EPIGENOMICS AG NA O.N./  DE000A32VN83  /

TradeGate
9/27/2023  7:24:06 PM Chg. -0.07 Volume Bid9:58:00 PM Ask9:58:00 PM High Low
0.59EUR -10.00% 10,600
Turnover: 6,341		 0.52Bid Size: 2,100 0.59Ask Size: 10,000 0.63 0.59
GlobeNewswire 3/16/2022 Progenity to Report Fourth Quarter and Full-Year 2021 Financial Results and Provide Corporate Update
GlobeNewswire 2/28/2022 Progenity Announces Acceptance of Three Abstracts at Digestive Disease Week 2022
GlobeNewswire 2/16/2022 Progenity Shares Oral Presentation on Treatment of Gastrointestinal Disorders at 34th Belgian Week o...
GlobeNewswire 1/25/2022 Progenity Strengthens Intellectual Property for Single-Molecule Detection Technology with Additional...
GlobeNewswire 1/11/2022 Progenity Announces Oral Presentation on Treatment of Gastrointestinal Disorders at 34th Belgian Wee...
GlobeNewswire 1/5/2022 Progenity Announces Acceptance of Two Abstracts on Treatment of Gastrointestinal Disorders at ECCO’2...
GlobeNewswire 1/3/2022 Progenity to Participate in the H.C. Wainwright BIOCONNECT Virtual Conference
GlobeNewswire 12/20/2021 Progenity Completes Exit from Laboratory Business with Sale of Affiliate Lab
GlobeNewswire 12/2/2021 Progenity Announces New Patent for Single-Molecule Detection Technology
GlobeNewswire 11/23/2021 Progenity Strengthens its Liquidity Position
GlobeNewswire 11/15/2021 Progenity to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference
GlobeNewswire 11/11/2021 OpGen Reports Third Quarter 2021 Financial Results and Provides Business Update
GlobeNewswire 11/10/2021 Progenity Provides Corporate Update and Reports Third Quarter 2021 Financial Results
GlobeNewswire 11/9/2021 Progenity Appoints Adi Mohanty as Chief Executive Officer
GlobeNewswire 11/4/2021 OpGen Appoints Albert Weber as Chief Financial Officer
GlobeNewswire 11/4/2021 Progenity Announces Appointment of Jill Howe to its Board of Directors
GlobeNewswire 11/3/2021 Progenity to Report Third Quarter 2021 Financial Results and Provide Corporate Update
GlobeNewswire 11/2/2021 PacBio’s Sequel IIe Selected by Prenetics to Build Personalized Genomics for Healthcare
GlobeNewswire 10/26/2021 Progenity Reduces Outstanding Debt by $20.175 Million Through a Private Exchange of $20.175 Million ...
GlobeNewswire 10/19/2021 Progenity to Participate in Crohn’s & Colitis Foundation’s Fourth Annual IBD Innovate Conference
GlobeNewswire 10/13/2021 Progenity Announces Several Patents Granted by USPTO, Strengthening the Company’s Intellectual Prope...
GlobeNewswire 10/6/2021 Progenity Announces Closing of $20 Million Registered Direct Offering of Common Stock Priced at Prem...
GlobeNewswire 10/4/2021 Progenity Announces $20 Million Registered Direct Offering of Common Stock Priced at Premium to Mark...
GlobeNewswire 9/21/2021 Progenity to Participate in 11th Annual Partnership Opportunities in Drug Delivery Conference
GlobeNewswire 9/14/2021 Progenity Announces Patent Granted by USPTO for its Preeclampsia Rule-Out Test